Metabolomics in various Diseases
Metabolomics is a novel approach that potentials to enable the detection of states of disease, to categories the patients based on biochemical profiles and to monitor disease progression. Metabolomic analysis may also be able to orient the choice of therapy, identify responders and predict toxicity, paving the way to a customized therapy.
- Metabolomics in Neuropsychiatric Disorders: Metabolomics approach has revealed new opportunities in diagnostics of devastating disorders like neuropsychiatric disorders. Metabolomics-based technologies have the prospective to map early biochemical fluctuations in disease and hence provide a prospect to develop predictive biomarkers that can be used as indicators of pathological deviations prior to development of clinical symptoms of neuropsychiatric disorders.
- Metabolomics in Metabolic Disorders: Metabolomics uses in the identification of metabolites not previously associated with metabolic traits highlight the importance and agitations of particular metabolites and advances novel strategies to prevent type 2 diabetes and illustrate biomarkers that can help with early detection, disease progression and therapeutic response. Consequently, the use of metabolomics in this area will continue to grow in basic research science and clinical medical applications.
- Metabolomics in Cardiovascular Diseases: Cardiovascular diseases are the leading causes of death worldwide. There is a need for the development of particular diagnostic techniques, more effective therapeutic procedures as well as drugs, which can decrease the mortality rate in the course of CVDs. Metabolomic technologies may serve as diagnostic and/or prognostic tools that have the potential to significantly alter the management of CVD. Metabolomics can assist in the interpretation of perturbed metabolic processes, and improves our ability to understand the pathology of ischemic heart disease, atherosclerosis, and heart failure.
- Metabolomic studies in Rheumatoid Arthritis: Metabolites from the nucleic acid and oxidative stress pathways are potential biomarkers for rheumatoid arthritis pathology. Metabolite profiles in rheumatoid arthritis plasma are associated to disease activity and treatment response. Metabolomic studies confirm the hypoxic nature of the inflamed synovial joint in rheumatoid arthritis.
- Metabolomic studies in Systemic Lupus Erythematous: Low histidine levels have been identified in the serum of systemic lupus erythematosus (SLE) and RA could explain the increased incidence of cardiovascular disease observed for both rheumatic diseases. Taurine and citrate levels in the SLE urine metabolome have potential utility as biomarkers for SLE nephritis subtype discrimination.
- studies in Ankylosing Spondylitis: Metabolite levels in serum reflect an alteration in the vitamin D3 metabolism in ankylosing spondylitis. Metabolomic studies of patients and controls identified reduced levels of tryptophan in ankylosing spondylitis, probably due to IFN-γ expression in the disease.
- Metabolomic studies in Psoriatic Arthritis: To date, no studies have directly compared psoriatic arthritis and psoriasis metabolomics profiles. The urine metabolome in psoriatic arthritis is correlated with the changes in disease activity induced by anti-TNF treatment.
- Metabolomic studies in Osteoarthritis: The prediction model built from the urine metabolite concentrations correlates significantly with the Kellgren–Lawrence radiographic scores of osteoarthritis severity. The valine/histidine and the xleucine(isoleucine and leucine)/histidine ratios are potential biomarkers of the development of knee osteoarthritis.
- Metabolomic studies in Gouty Arthritis: Uric acid is not a sufficiently informative biomarker of gouty arthritis and additional markers must be identified. Gouty arthritis also expresses the common core of serum metabolites found in other prevalent arthritis. This common set of metabolites could be useful for the development of improved diagnostic systems.
- Metabolomics in Nephrology: The application of metabolomics in nephrology research has expanded from the initial analyses of uraemia to include both cross-sectional and longitudinal studies of earlier stages of kidney disease. Chronic kidney disease, Diabetic nephropathy, Acute kidney injury, Kidney transplantation and End-stage renal disease
- Metabolomics in Neuropsychiatric Disorders
- Metabolomics in Metabolic Disorders
- Metabolomics in Cardiovascular Diseases
- Metabolomic studies in Rheumatoid Arthritis
- Metabolomic studies in Systemic Lupus Erythematous
- Metabolomic studies in Ankylosing Spondylitis
- Metabolomic studies in Psoriatic Arthritis
- Metabolomic studies in Osteoarthritis
- Metabolomic studies in Gouty Arthritis
- Metabolomics in Nephrology
Related Conference of Metabolomics in various Diseases
May 15-16, 2023
15th International Conference on Tissue Science and Regenerative Medicine
Prague, Czech Republic
September 27-28, 2023
7th International Conference on Biochemistry & Molecular Biology
Paris, France
October 30-31, 2023
4th International Conference on Polymer Waste - Biopolymers & Bioplastics
Rome, Italy
Metabolomics in various Diseases Conference Speakers
Recommended Sessions
- Analytical Techniques in Metabolomics
- Computational Methodologies
- Mass Spectroscopy (Ms) based Metabolomics
- Metabolic Modelling and Synthetic Biology
- Metabolomic in the field of Paediatric Medicine
- Metabolomics
- Metabolomics Applications
- Metabolomics Approaches
- Metabolomics in detection of Chemotoxicity
- Metabolomics in Discovering Biomarkers
- Metabolomics in Drug Discovery
- Metabolomics in Nutrition Research
- Metabolomics in Pharmaceutics
- Metabolomics in Precision Medicine
- Metabolomics in Systems Biology
- Metabolomics in the field Of Oncology / Cancer Metabolomic
- Metabolomics in various Diseases
- Nmr-based Metabolomics
- Pharmaco-metabolomics
- Plant and Environmental Metabolomics
- Systems Biology
Related Journals
Are you interested in
- 3-D Structure Determination - Structural Biology-2023 (France)
- 3D Bioprinting in tissue engineering - Cell Tissue Science 2023 (Italy)
- A New Approach to Determining the Nucleic Acid Sequence - NUCLEIC ACID CONF 2023 (UK)
- Advancements in Structural Biology - Structural Biology-2023 (France)
- Analytical Techniques in Metabolomics - Eurometabolomics-2023 (Italy)
- Applications of Tissue Engineering - Cell Tissue Science 2023 (Italy)
- Artificial Nucleic Acid - NUCLEIC ACID CONF 2023 (UK)
- Artificial Organs - Cell Tissue Science 2023 (Italy)
- Bio Banking - Cell Tissue Science 2023 (Italy)
- Bio Equivalence Assessment - BIOSIMILARS 2023 (France)
- Bio fabrication & 3 D-Bio printing in Life Sciences - Cell Tissue Science 2023 (Italy)
- Bio Pharmaceuticals - BIOSIMILARS 2023 (France)
- Biochemistry - Glycobiology 2023 (Italy)
- Biochemistry and Biophysics - Structural Biology-2023 (France)
- Biochemistry for Material Science: - Biochemistry 2023 (France)
- Biochips and Tissue Chips - Cell Tissue Science 2023 (Italy)
- Bioenergy and Bio-renewables - biosensorscongress-2023 (UK)
- Bioinstrumentation - biosensorscongress-2023 (UK)
- Biologics - BIOSIMILARS 2023 (France)
- Biomarkers - BIOSIMILARS 2023 (France)
- Biomarkers - Structural Biology-2023 (France)
- Biomaterials - biosensorscongress-2023 (UK)
- Biomaterials Engineering - Cell Tissue Science 2023 (Italy)
- Biomedical Engineering - biosensorscongress-2023 (UK)
- Biomedical Engineering Techniques - Cell Tissue Science 2023 (Italy)
- Biomedical Polymer and Metal Materials - biosensorscongress-2023 (UK)
- Biopharmaceuticals - biosensorscongress-2023 (UK)
- Bioprocessing - biosensorscongress-2023 (UK)
- Biosensors for Environmental Monitoring - biosensorscongress-2023 (UK)
- Biosensors in Drug Discovery - biosensorscongress-2023 (UK)
- Biosensors, Bio-sensing Technologies - biosensorscongress-2023 (UK)
- Biosimilars - BIOSIMILARS 2023 (France)
- Biosimilars and Biologics - BIOSIMILARS 2023 (France)
- Bone and Cartilage Tissue Engineering - Cell Tissue Science 2023 (Italy)
- Bone Tissue Engineering - Cell Tissue Science 2023 (Italy)
- Cancer Biotechnology - biosensorscongress-2023 (UK)
- Cardiovascular Biochemistry: - Biochemistry 2023 (France)
- Cell and Organ Regeneration - Cell Tissue Science 2023 (Italy)
- Cell Science - Cell Tissue Science 2023 (Italy)
- Cell Therapy - Cell Tissue Science 2023 (Italy)
- Cell therapy bioprocessing and commercialization - biosensorscongress-2023 (UK)
- Cellular and gene Therapies - Cell Tissue Science 2023 (Italy)
- Chemical Biology and Computational Chemistry: - Biochemistry 2023 (France)
- Chemoinformatic Drug Discovery - DRUG CHEMISTRY CONF 2023 (UK)
- Clinical Development of Bio Similars - BIOSIMILARS 2023 (France)
- Clinical Pathology: - Biochemistry 2023 (France)
- Clinical Trials and Clinical Research - biosensorscongress-2023 (UK)
- Clinical Trials and Regulatory Affairs in Pharmacy - DRUG CHEMISTRY CONF 2023 (UK)
- Computational Approaches in Structural Biology - Structural Biology-2023 (France)
- Computational Methodologies - Eurometabolomics-2023 (Italy)
- Computer backed Drug Designing - DRUG CHEMISTRY CONF 2023 (UK)
- Corona Virus Drug Discovery - DRUG CHEMISTRY CONF 2023 (UK)
- COVID 19 and Biochemistry: - Biochemistry 2023 (France)
- Dendritic cells - Cell Tissue Science 2023 (Italy)
- DNA Damage and Repair - NUCLEIC ACID CONF 2023 (UK)
- Drug Delivery Devices - DRUG CHEMISTRY CONF 2023 (UK)
- Drug Designing - Structural Biology-2023 (France)
- Drug Designing Methodologies - DRUG CHEMISTRY CONF 2023 (UK)
- Drug Regulations Quality Assurance - biosensorscongress-2023 (UK)
- Effect of Nucleic Acid on Protein Synthesis - NUCLEIC ACID CONF 2023 (UK)
- Emerging Biosimilars in Therapeutics - BIOSIMILARS 2023 (France)
- Environmental Biosensors - biosensorscongress-2023 (UK)
- Enzyme-Based Biosensors - biosensorscongress-2023 (UK)
- Enzymes for Nucleic Acids - NUCLEIC ACID CONF 2023 (UK)
- Enzymology and Biochemistry: - Biochemistry 2023 (France)
- Enzymology in Molecular Biology: - Biochemistry 2023 (France)
- Evolution of Glycan Diversity - Glycobiology 2023 (Italy)
- Frontiers in Structural Biology - Structural Biology-2023 (France)
- Function of Nucleic Acid - NUCLEIC ACID CONF 2023 (UK)
- Gene and Immunotherapy - Cell Tissue Science 2023 (Italy)
- Gene Regulation and Cell Signaling - Structural Biology-2023 (France)
- Genome Informatics - Structural Biology-2023 (France)
- Genomics and Metabolomics - Glycobiology 2023 (Italy)
- Globilization of Bio Similars - BIOSIMILARS 2023 (France)
- Glycan’s - Glycobiology 2023 (Italy)
- Glycans in Diseases and Therapeutics - Glycobiology 2023 (Italy)
- Glycans in Drug Design - Glycobiology 2023 (Italy)
- Glycobiology - Glycobiology 2023 (Italy)
- Glycochemistry - Glycobiology 2023 (Italy)
- Glycoimmunology - Glycobiology 2023 (Italy)
- Glycoinformatics - Glycobiology 2023 (Italy)
- Glycolipids and Glycopeptides - Glycobiology 2023 (Italy)
- Glyconeurobiology - Glycobiology 2023 (Italy)
- Glycopathology - Glycobiology 2023 (Italy)
- Glycoscience - Glycobiology 2023 (Italy)
- Industrial Biotechnology - biosensorscongress-2023 (UK)
- Infectious Disease - NUCLEIC ACID CONF 2023 (UK)
- Lab-on-a-chip and Multiplexed Sensors - biosensorscongress-2023 (UK)
- Lipids and Metabolism: - Biochemistry 2023 (France)
- Mass Spectroscopy (Ms) based Metabolomics - Eurometabolomics-2023 (Italy)
- Mast cells - Cell Tissue Science 2023 (Italy)
- Materials and Designs for Tissue Engineering - Cell Tissue Science 2023 (Italy)
- Medical bias for Drug Delivery - DRUG CHEMISTRY CONF 2023 (UK)
- Medical Genetics: - Biochemistry 2023 (France)
- Medicine Chemistry - DRUG CHEMISTRY CONF 2023 (UK)
- Metabolic Modelling and Synthetic Biology - Eurometabolomics-2023 (Italy)
- Metabolomics - Eurometabolomics-2023 (Italy)
- Metabolomics Applications - Eurometabolomics-2023 (Italy)
- Metabolomics Approaches - Eurometabolomics-2023 (Italy)
- Metabolomics in Systems Biology - Eurometabolomics-2023 (Italy)
- Metabolomics in the field of Oncology / Cancer Metabolomics - Eurometabolomics-2023 (Italy)
- Microfluidics-Technology & Healthcare - biosensorscongress-2023 (UK)
- Molecular and Cellular Biology: - Biochemistry 2023 (France)
- Molecular and Structural Biochemistry: - Biochemistry 2023 (France)
- Molecular Biology - NUCLEIC ACID CONF 2023 (UK)
- Molecular Biology - Structural Biology-2023 (France)
- Molecular Biology and Material Science: - Biochemistry 2023 (France)
- Molecular Modeling and Dynamics - Structural Biology-2023 (France)
- Molecular Modelling in Drug Designing - DRUG CHEMISTRY CONF 2023 (UK)
- Molecular Structure of Nucleic Acid - NUCLEIC ACID CONF 2023 (UK)
- Molecular Virology: - Biochemistry 2023 (France)
- Nano Biochemistry: - Biochemistry 2023 (France)
- Nanoparticles in Biopharmaceuticals - biosensorscongress-2023 (UK)
- New Trends in Pharmacology and Drug Development - DRUG CHEMISTRY CONF 2023 (UK)
- NMR & Mass Spectrophotometry - Structural Biology-2023 (France)
- Nmr-based Metabolomics - Eurometabolomics-2023 (Italy)
- Nucleic Acid as a Genetic Material - NUCLEIC ACID CONF 2023 (UK)
- Nucleic Acid Bases - NUCLEIC ACID CONF 2023 (UK)
- Nucleic Acid Probes - NUCLEIC ACID CONF 2023 (UK)
- Nucleic Acid Recognition - NUCLEIC ACID CONF 2023 (UK)
- Nutritional and Clinical Biology: - Biochemistry 2023 (France)
- Optical Biosensors - biosensorscongress-2023 (UK)
- Peptide Nucleic Acid as Therapeutic Agent - NUCLEIC ACID CONF 2023 (UK)
- Pharmaceutical and Medicine Biochemistry: - Biochemistry 2023 (France)
- Pharmaceutical Drug Discovery and Nanotechnology - DRUG CHEMISTRY CONF 2023 (UK)
- Pharmaceutical formulation, in pharmaceutics - biosensorscongress-2023 (UK)
- Pharmaceutical Nanotechnology - biosensorscongress-2023 (UK)
- Pharmaceutical Organic Chemistry - DRUG CHEMISTRY CONF 2023 (UK)
- Pharmacology and Toxicology: - Biochemistry 2023 (France)
- Pharmacometabolomics - Eurometabolomics-2023 (Italy)
- Pharmacovigilance Challenges in Biosimilars - BIOSIMILARS 2023 (France)
- Pharmacovigilance and Drug Safety - DRUG CHEMISTRY CONF 2023 (UK)
- Plant and Environmental Metabolomics - Eurometabolomics-2023 (Italy)
- Plant Animal Biochemistry: - Biochemistry 2023 (France)
- Protein and Analytical Biochemistry: - Biochemistry 2023 (France)
- Proteoglycan and Sialic acid - Glycobiology 2023 (Italy)
- Proteomics & Bioinformatics Drug Discovery - DRUG CHEMISTRY CONF 2023 (UK)
- Proteomics and Genomics - Structural Biology-2023 (France)
- Recent Advances in Glycobiology - Glycobiology 2023 (Italy)
- Recombinant DNA Technology - NUCLEIC ACID CONF 2023 (UK)
- RNA Processing and Protein Synthesis - NUCLEIC ACID CONF 2023 (UK)
- Sequencing Analysis - Structural Biology-2023 (France)
- Soft Tissue Replacement - Cell Tissue Science 2023 (Italy)
- Structural Biochemistry: - Biochemistry 2023 (France)
- Structural Bioinformatics - Structural Biology-2023 (France)
- Structural Biology - Structural Biology-2023 (France)
- Structural Biology of Membrane Proteins - Structural Biology-2023 (France)
- Structural Enzymology - Structural Biology-2023 (France)
- Structural Molecular Biochemistry and Structural Bioinformatics: - Biochemistry 2023 (France)
- Structural Virology - Structural Biology-2023 (France)
- Study of a set of proteins in Biochemistry and Molecular Biology: - Biochemistry 2023 (France)
- Synthesis and Biological Role of Glycans - Glycobiology 2023 (Italy)
- Systems Biology - Eurometabolomics-2023 (Italy)
- Thermodynamics of Nucleic Acids - NUCLEIC ACID CONF 2023 (UK)
- Tissue Culture & Preservation - Cell Tissue Science 2023 (Italy)
- Tissue Engineering& DNA Technology Drug Therapies - biosensorscongress-2023 (UK)
- Tissue Repair and Regeneration - Cell Tissue Science 2023 (Italy)
- Tissue Science - Cell Tissue Science 2023 (Italy)
- Track 10: Amino Acids and RNA Biology - BIOCHEMISTRY MEET 2023 (UK)
- Track 11: Stem Cell - BIOCHEMISTRY MEET 2023 (UK)
- Track 12: Nanotechnology in Biochemistry - BIOCHEMISTRY MEET 2023 (UK)
- Track 14: Xenobiotic and Chemical Ecology - BIOCHEMISTRY MEET 2023 (UK)
- Track 15: Biochemistry in Cancer research - BIOCHEMISTRY MEET 2023 (UK)
- Track 16 Biochemistry in diseases and therapeutics - BIOCHEMISTRY MEET 2023 (UK)
- Track 17: Developmental Biology - BIOCHEMISTRY MEET 2023 (UK)
- Track 18: Next Generation Sequencing Data Analysis Technologies - BIOCHEMISTRY MEET 2023 (UK)
- Track 19 Physical Biochemistry - BIOCHEMISTRY MEET 2023 (UK)
- Track 1: Biochemistry - BIOCHEMISTRY MEET 2023 (UK)
- Track 2: clinical biochemistry - BIOCHEMISTRY MEET 2023 (UK)
- Track 3: Glycoproteomics and Protein Expression - BIOCHEMISTRY MEET 2023 (UK)
- Track 4: BIO ORGANIC CHEMISTRY - BIOCHEMISTRY MEET 2023 (UK)
- Track 5: Metabolic biochemistry - BIOCHEMISTRY MEET 2023 (UK)
- Track 6: Pharmaceutical Biochemistry - BIOCHEMISTRY MEET 2023 (UK)
- Track 7: Structural Biochemistry - BIOCHEMISTRY MEET 2023 (UK)
- Track 8: Forensic Biochemistry - BIOCHEMISTRY MEET 2023 (UK)
- Track 9: Animal Biochemistry - BIOCHEMISTRY MEET 2023 (UK)
- Track13 :Gene Expression and Genetic Engineering - BIOCHEMISTRY MEET 2023 (UK)
- Types of RNA - NUCLEIC ACID CONF 2023 (UK)
- Vaccine and medicine Delivery Systems - DRUG CHEMISTRY CONF 2023 (UK)